drugset / Trial / NCT02392026

Safety and Tolerability of Metronidazole Gel 1.3%

NCT02392026 ↗

Phase 4 Completed 60 enrolled Insud Pharma Allergan Sales, LLC · collab
NaSingle-groupOpen-labelTreatment

Summary

Multicenter, open-label study to evaluate safety and tolerability of Metronidazole Vaginal Gel in females 12 to \<18 years for the treatment of bacterial vaginosis.

Timeline

Start
2015-08-12
Primary completion
2016-10-05
Completion
2016-10-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule 1.3 % Other

Indications